ArticleDiscover oncology2025
Research trends and hotspots of Lamin family in cancer: a bibliometric analysis.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aims to use bibliometrics to visually analyze the role of the Lamin family in cancer, clarify the current research status, and determine research hotspots and future directions.
methodsWe searched the Web of Science Core Collection (WoSCC) on January 21, 2025, to identify literature published from January 1, 2005, to December 31, 2024, about the Lamin family ("Lamin A" or "Lamin B1" or "Lamin B2" or "LMNA" or "LMNB1" or " LMNB2") and "cancer" related literature. The authors, countries, institutions, published journals, literature co-citation, keyword co-occurrence, keyword clustering, and keyword bursts were analyzed using VOSviewer and CiteSpace software to construct a knowledge graph.
resultsA total of 136 publications were searched for research on the Lamin family in cancer, with the most research in breast (15 publications) and lung (11 publications) cancer. The overall number of publications on the field has increased over time with some fluctuations. China (56 publications) and the United States (30 publications) are the countries with the highest output of publications in this field, and the most prolific institutions and authors are "Central South University" and "xu, xiang-xi", respectively. Key themes include expression, cancer, tissues, LaminB1. Recent studies have focused on cellular senescence, therapeutic targets, nuclear lamellae, metastasis, and mechanisms, highlighting an expanding field of research. Thus, the role of Lamin family members in cancer development continues to be an emerging area of research.
conclusionBy analyzing global scientific research papers, we find that China leads in the "quantity" of research in this field, while the United States excels in "quality" and "impact" To foster better future development, scientists need to target emerging hotspots (such as "therapeutic targets") and collaborate with more outstanding teams. Administrators should not merely count the number of papers but focus on the quality of research outcomes and the depth of international collaboration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.